Sign in
Taking peopleNo phase

Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS)

Key facts

Who runs it
Nantes University Hospital
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
22 Feb 2024
Expected to end
30 Sept 2028
Type of study
Interventional
Treatments tested
  • Patients with severe to extreme anorexia nervosa admitted to hospital for refeeding
Record updated
14 November 2025

Who can take part

Age
15 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Women
  • Over 15 years old and 3 months
  • Admitted in the specialized department for eating disorders of CHU Nantes for refeeding
  • With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type)
  • Body Mass Index at admission below 16 kilogram per square meter
  • Written informed consent for patients over 18 years old/ oral informed consent from both the patient and a legal representative for patients under 18 years old
  • Affiliated with French social security system or beneficiary from such system

Who cannot take part

  • Who received a treatment with antibiotic/antifungal (other than local application) in the last three months
  • Who participate in another interventional study involving medication
  • Pregnant and breastfeeding women
  • Who had a weight gain in the last month (5% or more of the patient's weight at admission)
  • Under trusteeship or guardianship
  • Not fluent in French
  • Patients for whom stool collection or body mass composition analysis (with Dual-energy X-ray absorptiometry) couldn't be done during the first week of hospitalisation

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will investigate the link between the gut microbiota, the occurrence of the central adiposity phenotype, and the patients' fear to regain weight in anorexia nervosa.

The group in the trial

  • Anorexia nervosaTreatment being tested

    Treatment: Patients with severe to extreme anorexia nervosa admitted to hospital for refeeding

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
14 November 2025